antigenic and genetic diversity is observed between
the different genotypes. Reports of vaccine failure from many countries and reports by our lab on the
reduced ability of classical vaccines to significantly decrease viral replication and shedding have created
renewed interest in developing vaccines formulated with genotypes homologous to the virulent NDV
(vNDV) circulating in the field.